Jaguar Health (JAGX) Total Current Liabilities (2014 - 2026)
Jaguar Health's (JAGX) quarterly Total Current Liabilities came in at $40.7 million in Q1 2026, up 44.24% year-on-year from $28.2 million in Q1 2025, and little changed on a QoQ basis from $40.7 million in Q4 2025.
Jaguar Health (JAGX) Total Current Liabilities (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Total Current Liabilities data on file, last reported at $40.7 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 44.24% year-over-year to $40.7 million in Q1 2026; TTM through Mar 2026 was $40.7 million, a 44.24% increase from a year earlier, with the FY2025 full-year figure at $40.7 million, up 106.32% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $40.7 million, roughly flat from $40.7 million in the prior quarter.
- Over the last five years, Total Current Liabilities for JAGX reached as high as $40.7 million in Q1 2026 and fell as low as $12.5 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $25.7 million across 5 years, with a median of $26.9 million in 2022.
- Across the five-year window, Total Current Liabilities jumped 125.45% in 2022 and plunged 53.9% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $30.3 million in 2022, then plunged by 53.9% to $14.0 million in 2023, then jumped by 40.87% to $19.7 million in 2024, then surged by 106.32% to $40.7 million in 2025, then increased by 0.08% to $40.7 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $40.7 million in Q1 2026, $40.7 million in Q4 2025, and $36.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | 65.44 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 13.42 Mn |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 1.81 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 3.88 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 5.11 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | 1.58 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 1.35 Bn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | 289.60 Mn |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 40.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.69 Mn |
| Dec 31, 2025 | 40.65 Mn |
| Sep 30, 2025 | 36.12 Mn |
| Jun 30, 2025 | 29.22 Mn |
| Mar 31, 2025 | 28.21 Mn |
| Dec 31, 2024 | 19.70 Mn |
| Sep 30, 2024 | 19.87 Mn |
| Jun 30, 2024 | 19.13 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | 13.99 Mn |
| Sep 30, 2023 | 12.46 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 31.10 Mn |
| Dec 31, 2022 | 30.34 Mn |
| Sep 30, 2022 | 26.94 Mn |
| Jun 30, 2022 | 22.90 Mn |
| Mar 31, 2022 | 19.09 Mn |
| Dec 31, 2021 | 15.47 Mn |
| Sep 30, 2021 | 11.95 Mn |
| Jun 30, 2021 | 12.65 Mn |